AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 5 filers reported holding AMICUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,448 | +46.1% | 941,433 | +50.9% | 0.11% | +70.3% |
Q2 2023 | $7,836 | +353.5% | 623,853 | +300.3% | 0.06% | +357.1% |
Q1 2023 | $1,728 | +22.2% | 155,835 | +34.6% | 0.01% | -33.3% |
Q4 2022 | $1,414 | -100.0% | 115,791 | -60.5% | 0.02% | -47.5% |
Q3 2022 | $3,059,000 | +120.4% | 292,980 | +126.7% | 0.04% | +135.3% |
Q2 2022 | $1,388,000 | +478.3% | 129,234 | +522.6% | 0.02% | +750.0% |
Q4 2021 | $240,000 | -87.3% | 20,758 | -89.5% | 0.00% | -92.0% |
Q3 2021 | $1,889,000 | +121.7% | 197,771 | +123.7% | 0.02% | +177.8% |
Q2 2021 | $852,000 | -5.5% | 88,395 | -3.2% | 0.01% | -30.8% |
Q1 2021 | $902,000 | -51.9% | 91,337 | +12.5% | 0.01% | -27.8% |
Q4 2020 | $1,875,000 | +24.7% | 81,190 | -23.8% | 0.02% | -40.0% |
Q3 2020 | $1,504,000 | +232.7% | 106,516 | +129.3% | 0.03% | +275.0% |
Q4 2019 | $452,000 | +148.4% | 46,457 | +104.7% | 0.01% | +33.3% |
Q3 2019 | $182,000 | – | 22,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |